Moreover, abnormality thresholds of the core CSF AD biomarkers Aβ42/Aβ40, p-tau and total-tau defined primarily in non-Hispanic White cohorts do not appear to be generalizable to people from other racial and ethnic backgrounds [22, 34, 35]. The gene discussed is MAPT; the disease is Alzheimer disease.